Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
Alle Spezies anzeigen
Weitere Synonyme anzeigen
Wählen Sie die Spezies und Applikation aus
anti-Human Retinoic Acid Receptor alpha Antikörper:
anti-Mouse (Murine) Retinoic Acid Receptor alpha Antikörper:
anti-Rat (Rattus) Retinoic Acid Receptor alpha Antikörper:
Sie gelangen zu unserer vorgefilterten Suche.
Cow (Bovine) Monoclonal Retinoic Acid Receptor alpha Primary Antibody für WB - ABIN533539
Abu, Batuwangala, Herbert, Symonds: Retinoic acid and retinoid receptors: potential chemopreventive and therapeutic role in cervical cancer. in The Lancet. Oncology 2005
Show all 3 Pubmed References
Human Monoclonal Retinoic Acid Receptor alpha Primary Antibody für EMSA, ICC - ABIN2668711
Reichrath, Mittmann, Kamradt, Müller: Expression of retinoid-X receptors (-alpha,-beta,-gamma) and retinoic acid receptors (-alpha,-beta,-gamma) in normal human skin: an immunohistological evaluation. in The Histochemical journal 1997
Show all 2 Pubmed References
Human Monoclonal Retinoic Acid Receptor alpha Primary Antibody für IHC (p), ELISA - ABIN519635
Voss, Collin, Dixon, Thomas: Moz and retinoic acid coordinately regulate H3K9 acetylation, Hox gene expression, and segment identity. in Developmental cell 2009
Human Polyclonal Retinoic Acid Receptor alpha Primary Antibody für IHC (p), IHC - ABIN268790
Farias, Ong, Ghyselinck, Nakajo, Kuppumbatti, Mira y Lopez: Cellular retinol-binding protein I, a regulator of breast epithelial retinoic acid receptor activity, cell differentiation, and tumorigenicity. in Journal of the National Cancer Institute 2005
Human Monoclonal Retinoic Acid Receptor alpha Primary Antibody für IHC (fro), WB - ABIN152363
Choi, Park, Sockanathan: Activated retinoid receptors are required for the migration and fate maintenance of subsets of cortical neurons. in Development (Cambridge, England) 2014
Human Monoclonal Retinoic Acid Receptor alpha Primary Antibody für IHC, WB - ABIN4349382
Li, Hu, Hou, Wang, Wang, Yang, Gu, He, Shi, Chen, Song, Li: Alteration of the Retinoid Acid-CBP Signaling Pathway in Neural Crest Induction Contributes to Enteric Nervous System Disorder. in Frontiers in pediatrics 2018
Our results demonstrate that the majority of RARA-negative acute promyelocytic leukemia (APL) have RARB translocations, thereby forming a novel, distinct subgroup of APL. TBL1XR1-RARB as an oncogenic protein exerts effects similar to those of PML-RARA, underpinning the importance of retinoic acid pathway alterations in the pathogenesis of APL.
findings showed that the IRF2BP2-RARalpha fusion has the capacity to transform primary hematopoietic stem/progenitor cells and induced an ATRA-responsive acute promyelocytic leukemia (APL); this provides further evidence that formation of RARA fusion genes represent disease-defining mutations in APL pathogenesis
RARA and RARG gene downregulation associated with EZH2 mutation in acute promyelocytic-like morphology leukemia
BRD4 and PML/RARalpha co-existed on the same regulatory regions of their target genes. Hence, the study showed a new discovery of the interaction of BRD4 and PML/RARalpha, as well as the decline of PML/RARalpha expression in NB4 cells, under JQ1 treatment.
RARalpha contributed to the malignancy of Esophageal Carcinoma.
Despite the rarity of acute promyelocytic leukemia (APL) cases with an atypical PML/RARA fusion, our study indicates that an integrated laboratory approach, employing several diagnostic techniques is crucial to timely diagnose APL. This approach allows prompt initiation of specific targeted treatment and reliable MRD monitoring in atypical APL cases.
in response to RA, TRIM24 serves as an adapter linking RARalpha to the proteasome for its degradation. In addition, TRIM24 and the proteasome are recruited with RARalpha to the promoters of target genes and thus are inherently linked to RARalpha transcriptional activity.
increased expression of ALDH1A1-RDH10-RARalpha- PPARbeta/delta pattern could be considered as adverse prognostic factor associated with a higher concentration of paraprotein and worst overall survival of patients with newly diagnosed multiple myeloma.
The results of study demonstrate that increased level of expression in the first instance of isoform RARa in combination with hyper-expression of isoform RARbeta but not RARa can have unfavorable significance in case of evaluation of response to medicinal therapy and prognosis of total survival in patients with multiple melanoma.
Recurrent STAT3-RARA fusion is associated with acute promyelocytic leukemia lacking t(15;17)(q22;q12)/PML-RARA
PML and RARA breakpoint translocation is associated with acute promyelocytic leukemia.
Semiquantitative and quantitative analyses of the markers RARA and CRABP2 indicate their potential as biomarkers for tumor progression and their participation in nephroblastoma tumorigenesis
The level of RARalpha gene expression as a potential prognostic factor in the pathogenesis of multiple myeloma.
The data demonstrate that RARalpha drives integrin beta7-dependent adhesion and CCR9-mediated chemotaxis in CTCL cells.
These results therefore indicate that EGCG targets PML/RARalpha oncoprotein for degradation and potentiates differentiation of promyelocytic leukemia cells in combination with ATRA via PTEN.
Silencing of PML-RAR and RARalpha2 results in similar increases in the constitutive expression of several granulocytic differentiation markers.
RARA drives cyclin-dependent kinase expression, G1-S transition, and cell growth in T-cell lymphoma.
Demonstrate that RARalpha was frequently elevated in gastric carcinoma and exerted oncogenic properties via positive feedback loop of IL-1beta/Akt/RARalpha/Akt signaling.
Our findings unveil a novel essential oncogenic activity of PML/RARA in Acute promyelocitic leukemia
Findings reveal a previously unrecognized role of c-Myc as a potential ceRNA for PML/RARalpha in acute promyelocytic leukemia.
this study shows that RAR-alpha represses a Th9 transcriptional and epigenomic program to reduce allergic pathology
RARA produced in male germ cells has a broad spectrum of functions throughout spermatogenesis, which includes the maintenance of seminiferous epithelium organization, the integrity of the meiotic genome, and spermatogonial proliferation and differentiation.
This study used CRISPR technology to introduce biallelic frameshift mutations in RAR alpaha, RAR beta, and RAR gamma, thereby abrogating all RAR functions in murine embryonic stem cells. RAR-null cells display no changes in transcripts in response to All-trans-retinoic acid (RA), demonstrating that the RARs are essential for the regulation of all transcripts in murine embryonic stem cells in response to RA.
Data show that the development of langerhans cells (LC) from embryonic and bone marrow-derived progenitors and langerin(+ )conventional dendritic cells (DC) is regulated by the retinoic acid receptor alpha (RARalpha)-retinoic acid (RA) axis.
these findings indicate that epithelial cell-intrinsic RARalpha signaling is critical to the global development of the intestinal immune system
This study demonstrates that RA signaling is required in steroidogenic cells for their normal function and, thus, for male fertility.
RARalpha and RARgamma reciprocally control K5(+) progenitor cell proliferation and distribution in the developing submandibular salivary epithelium in a cell cycle-dependent manner while regulating lumenization independently of keratinizing differentiation
RARalpha competes with other PFN2a-binding proteins bearing PRMs and involved in actin filaments elongation. Consequently, the actin filament network is altered and MEFs adhesion is decreased. This novel role opens novel avenues for the understanding of pathologies characterized by increased levels of cytoplasmic RARalpha.
These data suggest that impairment of cardiac RARalpha signaling may be a novel mechanism that is directly linked to pathological stimuli-induced diastolic dysfunction.
Retinoic acid receptor alpha agonist all trans retinoic acid can protect the liver from ischemia reperfusion injury by promoting autophagy, which is dependent on Foxo3/p-Akt/Foxo1 signaling.
both the PML-RARA-driven competitive transplantation advantage and development of acute promyelocytic leukemia (APL) required DNMT3A
the reprogramming of epiblast stem cells into embryonic stem cell-like cells also requires low levels of retinoic acid (RA), which can modulate Wnt signalling through physical interactions of RARs with beta-catenin.
our findings challenge the predominant model in the field and we propose that PML/RARA initiates leukemia by subtly shifting cell fate decisions within the promyelocyte compartment.
DNA-binding-defective PML/RARA mutants could not repress the transcription of retinoic acid regulated genes.
although X-RARA fusion proteins have been suggested to act by blocking retinoid-dependent transcriptional programs , we observed a surprising paucity of natural retinoids capable of transactivating Gal4-RARA in primary mouse bone marrow cells
The results indicate a physiological role for RARgamma as a negative regulator of osteoclastogenesis in vivo and in vitro, and reveal distinct influences of RARalpha and RARgamma in bone structure regulation.
Data suggest that retinoic acid and GM-CSF-induced retinal dehydrogenase 2 (RALDH2) expression in dendritic cells requires cooperative binding of transcription factor Sp1 via the RA receptor/retinoid X receptor complex to the Aldh1a2 promoter.
Retinoic acid-RARalpha as a key component of the regulatory network governing maintenance and plasticity of Th1-cell fate.
atRA signaling mediated by RARa is required in the adult pancreas for maintaining both beta-cell function and mass
Data suggest that acute promyelocytic leukemia (APL) differentiation is a default program triggered by clearance of promyelocytic leukemia-retinoic acid receptor alpha fusion oncoprotein PML/RARA-bound promoters.
Increased expression of mammary TRbeta1 and DIO2, and decreased RXRalpha, provide a mechanism to increase thyroid hormone activity within the mammary gland during lactation.
Retinoic acid (RA)-responsive genes are differentially sensitive to alterations in the RA pathway and, in particular, cyp26a1 and raraa are under a high pressure to maintain signaling integrity.
The RA receptors RXR gamma and RAR alpha-b are expressed in patterns consistent with mediating the effects of RA on photoreceptors.
results show role for retinoic acid receptor as a regulator of spatial patterning of the pre-placodal ectoderm (PPE)through Tbx1 and RIPPLY3; demonstrate that Ripply3, acting downstream of RAR signaling, is key player in establishing boundaries in the PPE
This gene represents a nuclear retinoic acid receptor. The encoded protein, retinoic acid receptor alpha, regulates transcription in a ligand-dependent manner. This gene has been implicated in regulation of development, differentiation, apoptosis, granulopoeisis, and transcription of clock genes. Translocations between this locus and several other loci have been associated with acute promyelocytic leukemia. Alternatively spliced transcript variants have been found for this locus.
, nuclear receptor subfamily 1 group B member 1
, nucleophosmin-retinoic acid receptor alpha fusion protein NPM-RAR long form
, retinoic acid nuclear receptor alpha variant 1
, retinoic acid nuclear receptor alpha variant 2
, retinoic acid receptor alpha
, retinoic acid receptor, alpha polypeptide
, RAR alpha 1
, retinoic acid receptor, alpha
, retinoic acid receptor alpha-like
, nuclear receptor subfamily 1 group B member 1-A
, retinoic acid receptor alpha-2.A
, retinoic acid receptor alpha-A
, retinoic acid receptor, alpha 2a
, zRAR alpha
, rar alpha
, xRAR alpha
, retinoic acid receptor alpha 1 isoform
, nuclear receptor subfamily 1 group B member 1-B
, retinoic acid receptor alpha-2.B
, retinoic acid receptor alpha-B
, retinoic acid receptor, alpha 2b